<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We retrospectively compared morbidity and non-relapse mortality (NRM) after allogeneic bone marrow transplantation (BMT) in 236 adults with <z:hpo ids='HP_0001909'>leukemia</z:hpo> and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> conditioned with <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> plus oral versus intravenous <z:chebi fb="0" ids="28901">busulfan</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Our findings demonstrate that conditioning therapy with intravenous <z:chebi fb="0" ids="28901">busulfan</z:chebi> resulted in lower morbidity and NRM than did oral <z:chebi fb="0" ids="28901">busulfan</z:chebi> </plain></SENT>
</text></document>